IEFA - ETF AI Analysis
Top Page
iShares Core MSCI EAFE ETF (IEFA)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Leading Holding
The largest position, ASML Holding, has shown very strong performance, giving the fund a solid boost from its top holding.
Broad International Diversification
The ETF spreads its investments across many developed countries like Japan, the UK, and Europe, helping reduce the impact of problems in any single market.
Low Expense Ratio
The fund charges a very low fee, which means more of the investment returns stay in investors’ pockets over time.
Negative Factors
Reliance on One Standout Stock
ASML’s strong performance is a key driver of returns, so any weakness in this single stock could noticeably affect the fund.
Mixed Results Among Top Holdings
While several major positions have performed well, at least one large holding like AstraZeneca has been weak, slightly dragging on overall results.
Limited U.S. Exposure
The ETF has only a small allocation to U.S. stocks, so investors who want more exposure to the U.S. market would need to pair it with other funds.
IEFA vs. SPDR S&P 500 ETF (SPY)
AUM190.06B
RegionDeveloped Markets
Expense Ratio0.07%
Beta0.76
IssueriShares
Inception DateOct 18, 2012
Dividend Yield3.41%
Asset ClassEquity
Index TrackedMSCI EAFE IMI
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume9,008,572
30 Day Avg. Volume8,586,649
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
114.20Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2578
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IEFA Summary
IEFA is an ETF that follows the MSCI EAFE Investable Market Index, giving you broad exposure to stocks from developed countries outside North America, such as Japan, the UK, and Europe. It holds hundreds of companies of all sizes, including well-known names like Nestlé and HSBC, so you get instant global diversification in one investment. Someone might invest in IEFA to spread their money across many international markets and seek long-term growth beyond the U.S. stock market. A key risk is that international stocks can go up and down with global economic and currency changes.
How much will it cost me?The iShares Core MSCI EAFE ETF (IEFA) has an expense ratio of 0.07%, which means you’ll pay $0.70 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The iShares Core MSCI EAFE ETF (IEFA) could benefit from positive trends in developed markets outside North America, such as economic recovery in Europe or technological advancements in its top holdings like ASML and SAP. However, challenges like rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact sectors like financials and industrials, which make up a significant portion of the ETF's exposure.
IEFA Top 10 Holdings
IEFA’s story is driven by a mix of powerhouse European and Asian names. ASML is the clear engine, with its rising year-to-date performance giving the fund a strong semiconductor tailwind. Financial giants like HSBC and Mitsubishi UFJ are steadily supporting returns, while industrial player Siemens adds a modest boost. On the flip side, consumer staple Nestlé and pharma heavyweight AstraZeneca have been lagging, acting as a bit of a brake. Overall, the ETF leans toward developed markets in Europe and Japan, with broad sector exposure rather than a single-theme bet.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.58% | $4.89B | €559.30B | 68.69% | 76 Outperform | |
| HSBC Holdings | 1.30% | $2.45B | £243.52B | 48.09% | 80 Outperform | |
| Roche Holding AG | 1.28% | $2.43B | $367.47B | 26.72% | 73 Outperform | |
| Shell (UK) | 1.19% | $2.26B | £222.50B | 46.34% | 73 Outperform | |
| Novartis AG | 1.11% | $2.09B | CHF230.47B | 19.65% | 80 Outperform | |
| AstraZeneca | 1.01% | $1.92B | $262.47B | -0.89% | 80 Outperform | |
| Nestlé SA | 1.01% | $1.91B | CHF208.53B | -7.23% | 71 Outperform | |
| Mitsubishi UFJ Financial Group | 0.93% | $1.77B | ¥38.16T | 53.14% | 76 Outperform | |
| SAP SE | 0.91% | $1.73B | €234.97B | -13.74% | 66 Neutral | |
| Siemens | 0.89% | $1.69B | €206.31B | 13.85% | 74 Outperform |
IEFA Technical Analysis
Neutral
―
Price Trends
98.92
Negative
97.80
Negative
95.21
Positive
Market Momentum
-0.69
Negative
44.44
Neutral
47.46
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IEFA, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 97.12, equal to the 50-day MA of 98.92, and equal to the 200-day MA of 95.21, indicating a neutral trend. The MACD of -0.69 indicates Negative momentum. The RSI at 44.44 is Neutral, neither overbought nor oversold. The STOCH value of 47.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IEFA.
IEFA Peer Comparison
Comparison Results
Performance Comparison
IEFA
iShares Core MSCI EAFE ETF
96.53
10.79
12.58%
EFA
iShares MSCI EAFE ETF
―
―
―
EFV
iShares MSCI EAFE Value ETF
―
―
―
ESGD
iShares ESG Aware MSCI EAFE ETF
―
―
―
FENI
Fidelity Enhanced International ETF
―
―
―
JIRE
JPMorgan International Research Enhanced Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents